Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

OptimizeRx (OPRX) Non Operating Income (2016 - 2026)

OptimizeRx's Non Operating Income history spans 16 years, with the latest figure at -$1.1 million for Q4 2025.

  • On a quarterly basis, Non Operating Income rose 23.0% to -$1.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$4.7 million, a 16.43% increase, with the full-year FY2025 number at -$4.7 million, up 16.48% from a year prior.
  • Non Operating Income hit -$1.1 million in Q4 2025 for OptimizeRx, down from -$1.0 million in the prior quarter.
  • Over the last five years, Non Operating Income for OPRX hit a ceiling of $721000.0 in Q2 2023 and a floor of -$1.5 million in Q1 2024.
  • Historically, Non Operating Income has averaged -$415786.2 across 5 years, with a median of $467.0 in 2021.
  • Biggest five-year swings in Non Operating Income: soared 22166566.67% in 2023 and later crashed 329.47% in 2024.
  • Tracing OPRX's Non Operating Income over 5 years: stood at $2382.0 in 2021, then soared by 22507.56% to $538512.0 in 2022, then plummeted by 255.24% to -$836000.0 in 2023, then plummeted by 70.57% to -$1.4 million in 2024, then grew by 23.0% to -$1.1 million in 2025.
  • Business Quant data shows Non Operating Income for OPRX at -$1.1 million in Q4 2025, -$1.0 million in Q3 2025, and -$1.5 million in Q2 2025.